CellFE, a San Francisco Bay Area-based biotech startup developing intracellular delivery platform to enable engineering of life-saving therapies, has closed $4.8 million Series Seed round of financing to fuel the progress already underway towards developing CellFE’s innovative solution to enable the engineering […]